?>
bbyfog

CIOMS Draft Report Proposes Best Practices for Implementing AI Tools and Processes in Pharmacovigilance

This subreddit is for all things regulatory writing: clinical and regulatory guidance, regulations, legislation, guidelines, new research, templates, processes, tips, and best practices in medical writing. Plus biotech and Q&A.

bbyfog

Risk Factors Associated With Late-Onset Epilepsy in Dementia and Mild Cognitive Impairment

Neurological and neurodegenerative diseases and disorders -- scientific literature, clinical trials, and drug development. Note: related subs r/MultipleSclerosisLit (for MS) and r/BCellAutoimmuneDis (for neurological diseases with B cell etiology)

bbyfog

Roche granted FDA Breakthrough Device Designation for first AI-driven companion diagnostic for non-small cell lung cancer

This subreddit is for all things regulatory writing: clinical and regulatory guidance, regulations, legislation, guidelines, new research, templates, processes, tips, and best practices in medical writing. Plus biotech and Q&A.

bbyfog

FDA Announces Completion of First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout Timeline

This subreddit is for all things regulatory writing: clinical and regulatory guidance, regulations, legislation, guidelines, new research, templates, processes, tips, and best practices in medical writing. Plus biotech and Q&A.

bbyfog

FDA Advisory Committee Votes Favorably that the Data Support Arimoclomol as Effective Treatment for Patients with Niemann-Pick Disease Type C | Zevra Therapeutics, Inc.

Neurological and neurodegenerative diseases and disorders -- scientific literature, clinical trials, and drug development. Note: related subs r/MultipleSclerosisLit (for MS) and r/BCellAutoimmuneDis (for neurological diseases with B cell etiology)

bbyfog

EMA has launched a new page, “Regulatory acceptance of new approach methodologies (NAMs) to reduce animal use testing.“

This subreddit is for all things regulatory writing: clinical and regulatory guidance, regulations, legislation, guidelines, new research, templates, processes, tips, and best practices in medical writing. Plus biotech and Q&A.

bbyfog

FDA Commissioner Marty Makary Chooses Vinay Prasad from UCSF to lead CDER

This subreddit is for all things regulatory writing: clinical and regulatory guidance, regulations, legislation, guidelines, new research, templates, processes, tips, and best practices in medical writing. Plus biotech and Q&A.

bbyfog

AMWA’s Introductory Guide to Regulatory Writing

This subreddit is for all things regulatory writing: clinical and regulatory guidance, regulations, legislation, guidelines, new research, templates, processes, tips, and best practices in medical writing. Plus biotech and Q&A.

bbyfog

Missing REMS Delays Cytokinetics' heart drug Aficamten's PDUFA Date by 3 Months

This subreddit is for all things regulatory writing: clinical and regulatory guidance, regulations, legislation, guidelines, new research, templates, processes, tips, and best practices in medical writing. Plus biotech and Q&A.

bbyfog

EndPoints News: After FDA firings, drug reviewers are asked to volunteer for administrative work

This subreddit is for all things regulatory writing: clinical and regulatory guidance, regulations, legislation, guidelines, new research, templates, processes, tips, and best practices in medical writing. Plus biotech and Q&A.

bbyfog

Updated SPIRIT 2025 Checklist for Developing More Comprehensive and Complete Clinical Trial Protocols, Published in JAMA

This subreddit is for all things regulatory writing: clinical and regulatory guidance, regulations, legislation, guidelines, new research, templates, processes, tips, and best practices in medical writing. Plus biotech and Q&A.

bbyfog

Evaluation of United Kingdom (UK)—Windsor Framework and Comparison Against European Union (EU) Regulations for Medicines Regulation

This subreddit is for all things regulatory writing: clinical and regulatory guidance, regulations, legislation, guidelines, new research, templates, processes, tips, and best practices in medical writing. Plus biotech and Q&A.

bbyfog

Novavax Covid-19 Vaccine BLA Review by the FDA: Is Imposition of an Onerous Postmarketing Commitment a way to Stall Approval

This subreddit is for all things regulatory writing: clinical and regulatory guidance, regulations, legislation, guidelines, new research, templates, processes, tips, and best practices in medical writing. Plus biotech and Q&A.

bbyfog

My Experience with Medical/Regulatory Writing Position Job Search and What I Learned About the Current Job Market in the US

This subreddit is for all things regulatory writing: clinical and regulatory guidance, regulations, legislation, guidelines, new research, templates, processes, tips, and best practices in medical writing. Plus biotech and Q&A.

bbyfog

Potential Expiration or Sunsetting of the FDA’s Pediatric Priority Review Voucher Program

This subreddit is for all things regulatory writing: clinical and regulatory guidance, regulations, legislation, guidelines, new research, templates, processes, tips, and best practices in medical writing. Plus biotech and Q&A.

bbyfog

The Shingles Vaccine and Reduction of Dementia

Neurological and neurodegenerative diseases and disorders -- scientific literature, clinical trials, and drug development. Note: related subs r/MultipleSclerosisLit (for MS) and r/BCellAutoimmuneDis (for neurological diseases with B cell etiology)

bbyfog

HHS, FDA to Phase Out Petroleum-Based Synthetic Dyes in Nation’s Food Supply

This subreddit is for all things regulatory writing: clinical and regulatory guidance, regulations, legislation, guidelines, new research, templates, processes, tips, and best practices in medical writing. Plus biotech and Q&A.

bbyfog

China’s biotech market is staging a comeback that US biotech can only wish for

News about any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use. | Or we can talk about career advice. Whatever.

bbyfog

Robert Califf's Second Act: Substack - Califf's Commentary

This subreddit is for all things regulatory writing: clinical and regulatory guidance, regulations, legislation, guidelines, new research, templates, processes, tips, and best practices in medical writing. Plus biotech and Q&A.

bbyfog

FDA Commissioner Makary Proposes a Mechanism-based Conditional Approval Approach to Ultra-rare Diseases

This subreddit is for all things regulatory writing: clinical and regulatory guidance, regulations, legislation, guidelines, new research, templates, processes, tips, and best practices in medical writing. Plus biotech and Q&A.

bbyfog

Update on the PMDA Pediatric Requirement: Sponsors are Now Obligated to Prepare a Pediatric Drug Development Plan and Initiate Studies Including Japanese Children

This subreddit is for all things regulatory writing: clinical and regulatory guidance, regulations, legislation, guidelines, new research, templates, processes, tips, and best practices in medical writing. Plus biotech and Q&A.

bbyfog

Upcoming Conference: Mathematics of Neuroscience and AI

Neurological and neurodegenerative diseases and disorders -- scientific literature, clinical trials, and drug development. Note: related subs r/MultipleSclerosisLit (for MS) and r/BCellAutoimmuneDis (for neurological diseases with B cell etiology)

bbyfog

FYI - FDA has postponed the "Interested Parties Meeting: Implementation of the Best Pharmaceuticals for Children Act and Pediatric Research Equity Act" originally scheduled for 15 May

This subreddit is for all things regulatory writing: clinical and regulatory guidance, regulations, legislation, guidelines, new research, templates, processes, tips, and best practices in medical writing. Plus biotech and Q&A.

bbyfog

The Real-life Impact of FDA RIFs: The Story of Karen Hollitt, an Air Force Veteran and Former Employee at FDA’s Office of Pharmaceutical Quality

This subreddit is for all things regulatory writing: clinical and regulatory guidance, regulations, legislation, guidelines, new research, templates, processes, tips, and best practices in medical writing. Plus biotech and Q&A.

bbyfog

NICE recommends cladribine for treating active relapsing forms of multiple sclerosis

Multiple Sclerosis related literature including peer-reviewed scientific research, resources, news, and articles only from authentic sources such as MS societies, professional groups and websites, and mainstream news orgs (eg, NYT). ~~~> Welcome and join the subreddit to follow and comment.